Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Nilotinib (l01ea03), Without Administration Dispersed In Apple Sauce (pureed Apple) Within 2026-11-30
Germany Conclusion Of A Non-exclusive Drug Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V By Means Of An Open-house Model For The Active Ingredient Adalimumab (atc Code According To Who: L04ab04) 2026-11-30
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Substance Adalimumab (atc Code According To Who 2026-11-30
Germany Conclusion Of A Non-exclusive Drug Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V By Means Of An Open-house Model For The Active Ingredient Etanercep - Medicine 2026-11-30
Germany Conclusion Not Excluding Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Etanercept (atc Code According To Who 2026-11-30
United States Dla Medical Equipment Electronic Catalog (ecat) Generation V Program 2026-12-01
Germany Risedronic Acid (69.6 Mg)_tk, Hek, Hkk 2026-12-01
Germany Flucloxacillin (hkp, 500 Mg (n2, N3))_tk, Hek, Hkk 2026-12-01
Germany Cyanocobalamin (parenteral Drf)_tk, Hek, Hkk 2026-12-01
Germany Loratadine_tk 2026-12-01
Whats app